CalciumNEW2026-09

Investigating the Osteoprotective Potential of Holoptelia integrefolia through Multitarget Modulation of Bone Metabolic Pathways.

Verma Neha, Prajapati Apurva, Kumari Shilpa, Patel Hitesh D et al. — Applied biochemistry and biotechnology

Summary

This laboratory study explored how an extract from the plant *Holoptelea integrifolia* might help strengthen bones. Researchers found that this plant extract encouraged bone-forming cells to grow, multiply, and deposit more calcium, which is crucial for bone density. These findings suggest the plant could potentially offer new ways to support bone health and combat conditions like osteoporosis.

AI-generated summary — read the original

Key points

A plant extract from *Holoptelea integrifolia* was studied for its effects on bone cells.
The extract encouraged bone-forming cells to grow, multiply, and deposit calcium in lab tests.
It also showed interactions with proteins important for bone formation and inflammation.
These findings suggest the plant extract could have potential benefits for bone health.

What the study looked at

This laboratory study investigated whether an extract from the plant *Holoptelea integrifolia* could help protect bones and potentially combat osteoporosis, a condition characterized by weak and brittle bones. Researchers isolated a specific fraction (F1) from the plant and tested its effects on human bone-forming cells (osteoblasts) grown in a dish. They measured how well these cells survived and multiplied, their ability to produce bone-building enzymes, and how much calcium they deposited. The study also used computer simulations to predict how the plant's components might interact with key proteins involved in bone metabolism and inflammation. The study found that the plant extract significantly boosted the survival and growth of bone-forming cells. It also increased the activity of enzymes crucial for bone formation and led to greater calcium deposition, a key process for building strong bones. Computer models further supported that the plant's active compounds could interact with proteins that regulate bone growth and inflammation, suggesting multiple ways it might support bone health.

Dietary takeaway

While this lab study on a plant extract is promising for bone health, it's important to remember that it's an early finding and not a direct recommendation for dietary changes. For now, focus on established ways to support bone strength, such as ensuring adequate calcium intake through dairy products, leafy greens, and fortified foods, alongside vitamin D. Remember, one study alone doesn't provide definitive proof for human health benefits.

Abstract

Bone fragility and reduced bone mass are hallmarks of osteoporosis, which is characterized by microarchitectural deterioration. The anti-osteoporotic properties of fraction F1, which was separated from Holoptelea integrifolia, were evaluated in the present study using MG 63 osteoblastic cells. Analysis using GC-MS to find the bioactive components in fraction F1. Cell viability, alkaline phosphatase activity, mineralization assays, and in silico validation using molecular simulations to target the important osteoporotic proteins BMP2 and CCR2 were among the assays used to measure biological activity. It was discovered that cell viability increased with increasing concentrations, and the MG-63 cells had strong cytocompatibility and proliferation ability. Specifically, at 48 h, MTT-derived metabolic activity ranged from 72.48% of the untreated control at 1 µg/mL to 132.57% at 320 µg/mL, with the first concentration exceeding the untreated-control value observed at 20 µg/mL. Further, the ALP activity increased slightly from 0.611 to 0.615 U/mL at 7 days and from 0.616 to 0.620 U/mL at 14 days. The assay also showed slightly higher optical density at 14 days compared to the control, indicating increased calcium deposition. The main phytoconstituents in fraction F1 demonstrated strong binding affinity to BMP2 and CCR2 proteins in molecular docking tests, indicating positive outcomes in interacting with different osteogenic and inflammatory pathways. The molecular docking results were validated using 100 ns molecular simulations, which demonstrated that the complexes generated could bind. Therefore, the aforementioned findings clearly demonstrate that fraction F1 has potential for osteoblast differentiation, mineralization, and proliferation through protein interactions, indicating promising outcomes for its development as an anti-osteoporotic agent in future research.

View on PubMed →DOI: 10.1007/s12010-026-05888-3